Efficacy of open-label bismuth subsalicylate for the treatment of microscopic colitis
- 1 January 1998
- journal article
- clinical trial
- Published by Elsevier in Gastroenterology
- Vol. 114 (1) , 29-36
- https://doi.org/10.1016/s0016-5085(98)70629-8
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Collagenous colitis: a retrospective study of clinical presentation and treatment in 163 patients.Gut, 1996
- A Controlled Trial of Bismuth Subsalicylate in Infants with Acute Watery Diarrheal DiseaseNew England Journal of Medicine, 1993
- Collagenous colitis: a prospective trial of prednisolone in six patientsJournal of Internal Medicine, 1991
- Bismuth therapy in gastrointestinal diseasesGastroenterology, 1990
- Antisecretory and Antiinflammatory Properties of Bismuth SubsalicylateClinical Infectious Diseases, 1990
- In Vitro Antimicrobial Activity of Bismuth Subsalicylate and Other Bismuth SaltsClinical Infectious Diseases, 1990
- Lymphocytic (“microscopic”) colitis: A comparative histopathologic study with particular reference to collagenous colitisHuman Pathology, 1989
- EXACERBATION OF DIARRHOEA AND PAIN IN PATIENTS TREATED WITH 5-AMINOSALICYLIC ACID FOR ULCERATIVE COLITISThe Lancet, 1984
- Prevention of traveler's diarrhea (emporiatric enteritis). Prophylactic administration of subsalicylate bismuth)JAMA, 1980
- Effect of aspirin on normal and cholera toxin-stimulated intestinal electrolyte transport.Journal of Clinical Investigation, 1976